Zysset T, Bircher J
J Pharmacol Exp Ther. 1981 Apr;217(1):198-203.
The importance of the route of drug administration for drug ethanol interactions was studied using clomethiazole as model drug. To 10 rabbits equipped with permanently implanted catheters in the portal vein, the vena cava and the aorta respectively, clomethiazole was infused either into the portal vein or the vena cava and either together with i.v. saline or with i.v. ethanol. Arterial plasma clomethiazole and ethanol concentrations were measured by gas-liquid chromatography. After portal clomethiazole infusion, ethanol increased by the relative availability of clomethiazole to 270 +/- 90% (S.D.) of the saline controls, whereas after i.v. clomethiazole infusions the relative availability was increased only to 120 +/- 20% of the corresponding controls. Similarly, ethanol increased average plasma clomethiazole concentrations after 90 min of portal infusion from 5 to 14 nmol/ml, whereas after i.v. clomethiazole infusions the ethanol effect was small, the concentrations increasing only from 28 to 35 nmol/ml. These results are compatible with the concept that an ethanol-induced reduction of the hepatic capacity to metabolize a highly extracted drug is reflected to a much larger extent during first-pass elimination than during systemic clearance. Consequently, clinical toxicity in inebriated subjects is more likely to occur after oral than after parenteral administration of high extraction drugs.
以氯美噻唑作为模型药物,研究了给药途径对药物与乙醇相互作用的重要性。分别给10只门静脉、腔静脉和主动脉永久植入导管的家兔,将氯美噻唑注入门静脉或腔静脉,并分别与静脉注射生理盐水或静脉注射乙醇一起给药。通过气液色谱法测量动脉血浆中氯美噻唑和乙醇的浓度。门静脉注入氯美噻唑后,乙醇使氯美噻唑的相对生物利用度增加至生理盐水对照组的270±90%(标准差),而静脉注射氯美噻唑后,相对生物利用度仅增加至相应对照组的120±20%。同样,门静脉输注90分钟后,乙醇使血浆氯美噻唑平均浓度从5纳摩尔/毫升增加至14纳摩尔/毫升,而静脉注射氯美噻唑后,乙醇的作用较小,浓度仅从28纳摩尔/毫升增加至35纳摩尔/毫升。这些结果与以下概念相符,即乙醇诱导的肝脏代谢高摄取药物能力的降低在首过消除过程中比在全身清除过程中反映的程度要大得多。因此,在醉酒受试者中,高摄取药物口服给药后比注射给药后更易发生临床毒性反应。